Showing results (21-30 of 250) with videos related to
Sort By:
Pageof 25
Med (New York, N.Y.)|December 14, 2024
Novel agents for treating severe hypertriglyceridemiaAnthony S WierzbickiCardiovascular and Interventional Radiology|January 9, 2007
Lipid-altering therapies and the progression of atherosclerotic diseaseAnthony S WierzbickiBiochemical Society Transactions|October 25, 2007
Peroxisomal disorders affecting phytanic acid alpha-oxidation: a reviewA S WierzbickiExpert Review of Cardiovascular Therapy|January 23, 2024
Preventive cardiology for the aging population: how can we better design clinical trials of statins?Anthony S WierzbickiLupus|May 11, 2000
Lipids, cardiovascular disease and atherosclerosis in systemic lupus erythematosusA S WierzbickiDiabetes, Obesity & Metabolism|July 25, 2007
Interpreting clinical trials of diabetic dyslipidaemia: new insightsA S WierzbickiDiabetes & Vascular Disease Research|December 13, 2006
Fibrates after the FIELD study: Some answers, more questionsAnthony S WierzbickiInternational Journal of Clinical Practice|June 16, 2012
New directions in cardiovascular risk assessment: the role of secondary risk stratification markersA S WierzbickiDrug, Healthcare and Patient Safety|June 25, 2011
Safety and efficacy of laropiprant and extended-release niacin combination in the management of mixed dyslipidemias and primary hypercholesterolemiaAdie Viljoen, Anthony S WierzbickiExpert Opinion on Medical Diagnostics|March 19, 2013
Towards companion diagnostics for the management of statin therapyAdie Viljoen, Anthony S WierzbickiPageof 25